133 related articles for article (PubMed ID: 12757727)
1. Identification of mono- and bisubstrate inhibitors of protein farnesyltransferase and inducers of apoptosis from a pepticinnamin E library.
Thutewohl M; Kissau L; Popkirova B; Karaguni IM; Nowak T; Bate M; Kuhlmann J; Müller O; Waldmann H
Bioorg Med Chem; 2003 Jun; 11(12):2617-26. PubMed ID: 12757727
[TBL] [Abstract][Full Text] [Related]
2. Solid-phase synthesis of a pepticinnamin E library.
Thutewohl M; Waldmann H
Bioorg Med Chem; 2003 Jun; 11(12):2591-615. PubMed ID: 12757726
[TBL] [Abstract][Full Text] [Related]
3. Solid-phase synthesis and biological evaluation of a pepticinnamin E library.
Thutewohl M; Kissau L; Popkirova B; Karaguni IM; Nowak T; Bate M; Kuhlmann J; Müller O; Waldmann H
Angew Chem Int Ed Engl; 2002 Oct; 41(19):3616-20; 3516. PubMed ID: 12370908
[No Abstract] [Full Text] [Related]
4. Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate.
Schlitzer M; Böhm M; Sattler I; Dahse HM
Bioorg Med Chem; 2000 Aug; 8(8):1991-2006. PubMed ID: 11003144
[TBL] [Abstract][Full Text] [Related]
5. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
[TBL] [Abstract][Full Text] [Related]
6. Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Schlitzer M; Sattler I
Eur J Med Chem; 2000; 35(7-8):721-6. PubMed ID: 10960188
[TBL] [Abstract][Full Text] [Related]
7. Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
Koblan KS; Kohl NE; Omer CA; Anthony NJ; Conner MW; deSolms SJ; Williams TM; Graham SL; Hartman GD; Oliff A; Gibbs JB
Biochem Soc Trans; 1996 Aug; 24(3):688-92. PubMed ID: 8878827
[No Abstract] [Full Text] [Related]
8. Development of tripeptidyl farnesyltransferase inhibitors.
Lee HY; Sohn JH; Kwon BM
Bioorg Med Chem Lett; 2002 Jun; 12(12):1599-602. PubMed ID: 12039571
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors.
Tan KT; Guiu-Rozas E; Bon RS; Guo Z; Delon C; Wetzel S; Arndt S; Alexandrov K; Waldmann H; Goody RS; Wu YW; Blankenfeldt W
J Med Chem; 2009 Dec; 52(24):8025-37. PubMed ID: 19894725
[TBL] [Abstract][Full Text] [Related]
10. Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors.
Schlitzer M
Curr Pharm Des; 2002; 8(19):1713-22. PubMed ID: 12171543
[TBL] [Abstract][Full Text] [Related]
11. Non-thiol farnesyltransferase inhibitors: structure-activity relationships of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Schlitzer M; Böhm M; Sattler I
Bioorg Med Chem; 2002 Mar; 10(3):615-20. PubMed ID: 11814849
[TBL] [Abstract][Full Text] [Related]
12. Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones.
Mitsch A; Böhm M; Wissner P; Sattler I; Schlitzer M
Bioorg Med Chem; 2002 Aug; 10(8):2657-62. PubMed ID: 12057654
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
[TBL] [Abstract][Full Text] [Related]
14. Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: structural requirements of the central moiety for farnesyltransferase inhibitory activity.
Schlitzer M; Böhm M; Sattler I
Bioorg Med Chem; 2000 Oct; 8(10):2399-406. PubMed ID: 11058034
[TBL] [Abstract][Full Text] [Related]
15. UCF116, new inhibitors of farnesyltransferase produced by Streptomyces.
Hara M; Soga S; Itoh M; Shono K; Eishima J; Mizukami T
J Antibiot (Tokyo); 2000 Jul; 53(7):720-3. PubMed ID: 10994815
[No Abstract] [Full Text] [Related]
16. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of farnesyltransferase and Ras processing peptidase.
Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of farnesyltransferase and geranylgeranyltransferase-I for antitumor therapy: substrate-based design, conformational constraint and biological activity.
Dinsmore CJ; Bell IM
Curr Top Med Chem; 2003; 3(10):1075-93. PubMed ID: 12769709
[TBL] [Abstract][Full Text] [Related]
19. Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency.
Gwaltney SL; O'Connor SJ; Nelson LT; Sullivan GM; Imade H; Wang W; Hasvold L; Li Q; Cohen J; Gu WZ; Tahir SK; Bauch J; Marsh K; Ng SC; Frost DJ; Zhang H; Muchmore S; Jakob CG; Stoll V; Hutchins C; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2003 Apr; 13(7):1363-6. PubMed ID: 12657283
[TBL] [Abstract][Full Text] [Related]
20. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
